Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18776| Title: | BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC? | Austin Authors: | Arulananda, Surein;Mitchell, Paul L R | Affiliation: | Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia School of Cancer Medicine, La Trobe University, Heidelberg, Australia Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne, Parkville, Australia |
Issue Date: | Aug-2018 | Date: | 2018-07-02 | Publication information: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018; 13(8): 1055-1057 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/18776 | DOI: | 10.1016/j.jtho.2018.06.002 | ORCID: | 0000-0002-5636-6381 | Journal: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | PubMed URL: | 30056857 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.